A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer

This study has been completed.

Study NCT00664170 Information provided by Adventrx Pharmaceuticals

First Received: April 18, 2008 Last Updated: May 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)